Mingxiao Yang, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acupuncture Therapy | 18 | 2023 | 464 | 4.750 |
Why?
|
| Drugs, Chinese Herbal | 4 | 2023 | 144 | 1.780 |
Why?
|
| Acupuncture Points | 7 | 2023 | 101 | 1.640 |
Why?
|
| Moxibustion | 3 | 2017 | 8 | 1.220 |
Why?
|
| Electroacupuncture | 5 | 2021 | 60 | 1.150 |
Why?
|
| Plants, Medicinal | 1 | 2023 | 167 | 0.840 |
Why?
|
| Dysmenorrhea | 3 | 2018 | 86 | 0.810 |
Why?
|
| Low Back Pain | 3 | 2022 | 956 | 0.810 |
Why?
|
| Medicine, Traditional | 1 | 2021 | 91 | 0.750 |
Why?
|
| Plant Preparations | 1 | 2021 | 94 | 0.740 |
Why?
|
| Cellobiose | 1 | 2018 | 5 | 0.680 |
Why?
|
| Hypoxanthine | 1 | 2018 | 28 | 0.680 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 3 | 2023 | 1004 | 0.660 |
Why?
|
| Sucrose | 1 | 2018 | 164 | 0.630 |
Why?
|
| Analgesics | 3 | 2021 | 1040 | 0.610 |
Why?
|
| Migraine Disorders | 3 | 2020 | 1620 | 0.580 |
Why?
|
| Oleic Acid | 1 | 2016 | 85 | 0.550 |
Why?
|
| Constipation | 1 | 2021 | 546 | 0.550 |
Why?
|
| Medicine, Chinese Traditional | 2 | 2022 | 71 | 0.530 |
Why?
|
| Inositol | 1 | 2016 | 218 | 0.520 |
Why?
|
| Massage | 1 | 2014 | 85 | 0.490 |
Why?
|
| Metabolomics | 3 | 2024 | 1487 | 0.420 |
Why?
|
| Acupressure | 2 | 2021 | 16 | 0.390 |
Why?
|
| Pain Measurement | 8 | 2020 | 3420 | 0.380 |
Why?
|
| Randomized Controlled Trials as Topic | 10 | 2023 | 9944 | 0.350 |
Why?
|
| Neoplasms | 4 | 2023 | 21675 | 0.290 |
Why?
|
| Pain | 3 | 2020 | 4987 | 0.280 |
Why?
|
| Clinical Protocols | 4 | 2016 | 1459 | 0.270 |
Why?
|
| China | 6 | 2020 | 2243 | 0.260 |
Why?
|
| Research Design | 4 | 2019 | 5983 | 0.230 |
Why?
|
| Panax | 1 | 2023 | 29 | 0.220 |
Why?
|
| Blood Pressure | 1 | 2018 | 8551 | 0.220 |
Why?
|
| Seeds | 1 | 2023 | 105 | 0.220 |
Why?
|
| Glucose | 1 | 2014 | 4398 | 0.210 |
Why?
|
| Medicine, East Asian Traditional | 1 | 2022 | 17 | 0.210 |
Why?
|
| Tibet | 1 | 2021 | 11 | 0.200 |
Why?
|
| Hypertension | 2 | 2018 | 8480 | 0.200 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2023 | 245 | 0.200 |
Why?
|
| Diclofenac | 1 | 2021 | 71 | 0.190 |
Why?
|
| Antiemetics | 1 | 2022 | 177 | 0.190 |
Why?
|
| Tai Ji | 1 | 2024 | 285 | 0.180 |
Why?
|
| Mass Spectrometry | 2 | 2018 | 2203 | 0.180 |
Why?
|
| Defecation | 1 | 2021 | 188 | 0.170 |
Why?
|
| Endocrine System | 1 | 2019 | 113 | 0.160 |
Why?
|
| Spondylosis | 1 | 2019 | 81 | 0.160 |
Why?
|
| Complementary Therapies | 1 | 2023 | 485 | 0.160 |
Why?
|
| Neck Pain | 1 | 2019 | 180 | 0.160 |
Why?
|
| Humans | 37 | 2024 | 743811 | 0.150 |
Why?
|
| Bandages | 1 | 2018 | 266 | 0.140 |
Why?
|
| Treatment Outcome | 11 | 2023 | 63042 | 0.140 |
Why?
|
| Nervous System | 1 | 2019 | 554 | 0.140 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 1574 | 0.130 |
Why?
|
| Dyspepsia | 1 | 2016 | 115 | 0.120 |
Why?
|
| Electric Impedance | 1 | 2018 | 729 | 0.120 |
Why?
|
| Pain Perception | 1 | 2014 | 191 | 0.110 |
Why?
|
| Migraine without Aura | 1 | 2013 | 83 | 0.110 |
Why?
|
| Female | 18 | 2023 | 380020 | 0.100 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2016 | 370 | 0.100 |
Why?
|
| Headache | 1 | 2020 | 1224 | 0.100 |
Why?
|
| Pain Threshold | 1 | 2014 | 584 | 0.090 |
Why?
|
| Fertilization in Vitro | 1 | 2018 | 1283 | 0.090 |
Why?
|
| Bibliometrics | 1 | 2014 | 338 | 0.090 |
Why?
|
| Metabolome | 1 | 2016 | 894 | 0.080 |
Why?
|
| Genotype | 1 | 2023 | 12944 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3292 | 0.080 |
Why?
|
| Brain | 1 | 2014 | 26345 | 0.080 |
Why?
|
| Quality Improvement | 1 | 2023 | 3750 | 0.080 |
Why?
|
| Disability Evaluation | 1 | 2014 | 1828 | 0.070 |
Why?
|
| Sleep | 1 | 2023 | 4619 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3677 | 0.070 |
Why?
|
| Middle Aged | 7 | 2023 | 213241 | 0.070 |
Why?
|
| Young Adult | 6 | 2019 | 56392 | 0.070 |
Why?
|
| Adult | 11 | 2022 | 213889 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 20827 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2023 | 15518 | 0.060 |
Why?
|
| Arachidonic Acids | 1 | 2024 | 299 | 0.060 |
Why?
|
| Male | 9 | 2023 | 349776 | 0.060 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 3608 | 0.050 |
Why?
|
| Hong Kong | 1 | 2022 | 148 | 0.050 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7270 | 0.050 |
Why?
|
| Time Factors | 4 | 2018 | 40038 | 0.050 |
Why?
|
| Hot Flashes | 1 | 2023 | 316 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 11059 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 11729 | 0.040 |
Why?
|
| Hormones | 1 | 2024 | 889 | 0.040 |
Why?
|
| Phytotherapy | 1 | 2022 | 298 | 0.040 |
Why?
|
| Nausea | 1 | 2022 | 674 | 0.040 |
Why?
|
| Vomiting | 1 | 2022 | 636 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 13691 | 0.040 |
Why?
|
| Steroids | 1 | 2024 | 930 | 0.040 |
Why?
|
| Positron-Emission Tomography | 1 | 2014 | 6237 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 15067 | 0.040 |
Why?
|
| Aged | 4 | 2019 | 163178 | 0.040 |
Why?
|
| Publication Bias | 1 | 2018 | 162 | 0.040 |
Why?
|
| Amino Acids | 1 | 2024 | 1733 | 0.040 |
Why?
|
| Humidity | 1 | 2018 | 197 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2024 | 904 | 0.040 |
Why?
|
| Clomiphene | 1 | 2016 | 71 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2018 | 710 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 2018 | 643 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 2018 | 692 | 0.030 |
Why?
|
| Time | 1 | 2017 | 542 | 0.030 |
Why?
|
| Algorithms | 1 | 2016 | 13869 | 0.030 |
Why?
|
| Androgen Antagonists | 1 | 2023 | 1376 | 0.030 |
Why?
|
| Embryo Transfer | 1 | 2018 | 510 | 0.030 |
Why?
|
| Diarrhea | 1 | 2022 | 1348 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2019 | 1676 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3249 | 0.030 |
Why?
|
| Proline | 1 | 2016 | 457 | 0.030 |
Why?
|
| Alanine | 1 | 2016 | 571 | 0.030 |
Why?
|
| Fatigue | 1 | 2020 | 1530 | 0.030 |
Why?
|
| Glutamine | 1 | 2016 | 579 | 0.030 |
Why?
|
| Infertility, Female | 1 | 2018 | 788 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1516 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 20121 | 0.020 |
Why?
|
| Medical Records | 1 | 2017 | 1412 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2016 | 640 | 0.020 |
Why?
|
| Temperature | 1 | 2018 | 2202 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 783 | 0.020 |
Why?
|
| Animals | 2 | 2021 | 168660 | 0.020 |
Why?
|
| Quality of Life | 2 | 2023 | 12788 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 72252 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2018 | 2047 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15526 | 0.020 |
Why?
|
| Adolescent | 4 | 2019 | 85729 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2020 | 8316 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1529 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 3758 | 0.020 |
Why?
|
| Skin | 1 | 2018 | 4372 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 53250 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2016 | 6259 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2015 | 12020 | 0.010 |
Why?
|
| Inflammation | 1 | 2019 | 10629 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 19894 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2014 | 9139 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2016 | 21733 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 7908 | 0.010 |
Why?
|
| Prognosis | 1 | 2016 | 29052 | 0.010 |
Why?
|